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TREATMENT OF CARTILAGE LESIONS USING EXPANDED 
CARTILAGE CELLS SEEDED ON A THREE DIMENSIONAL 
FIBROUS SCAFFOLD BASED ON BENZYLIC ESTER OF 
HYALURONIC ACID -- PRELIMINARY CLINICAL RESULTS 
K-D Schatz 
Orthopaedics, University of Vienna, Austria 
Cartilage lesions of diarthroidal joints still represent a great chal- 
lenge for the orthopaedic surgeon as hyaline cartilage is well 
known for a poor capacity to heal. Tissue engineering of autolo- 
gous cartilage seems to be a promising method for repairing car- 
tilage defects in reconstructive surgery. However, the clinical 
experience with autologous cartilage implantation (ACI) has 
shown several imitations essentially related to complicated oper- 
ating procedures. To improve biological performance and surgical 
technique a smalt number of chondrocytes is initially isolated 
from a tiny cartilage biopsy. Then the cells are expanded in con- 
ventional monolayer cultures to provide a sufficient number of 
cells. Finally the cells are seeded into a scaffold structure to 
enable the organization of 3-dimensional configurations. After 
preparation of the lesion site the graft is directly adapted into the 
lesion without drilling. The graft then is fixed with a fibrin glue, no 
coverage of the defect with periosteum is performed. The redif- 
ferentiation potential of chondrocytes cultured within 3-D matri- 
ces made of biocompatible materials has been proved in recent 
studies. 
The current clinical experience is based on a 1.0 years follow-up 
of 13 patients treated at the Orthopaedic Department, University 
of Vienna. According to a prospective trial protocol the overall 
population was between 14 and 55 years. Knee joints were treat- 
ed without restrictions of size and number of cartilage defects or 
previous operations. Cartilage lesion grade III and IV according to 
the Outerbridge scale, Iocalisation on the medial or femoral 
condyle respectively patella lesions and a well balanced mechan- 
ical joint axis were further inclusion criteria. No cases of arthritis 
or infections respectively instable or malaligned knee joints were 
operated. The follow-up included MRI and clinical scores 
(Lysholm score and cartilage standard evaluation form) at 3, 6 
and 12 months. Study endpoint was defined with 3 years post- 
operatively. On the basis of the follow-up data available, patients 
showed immediate pain relief with good range of motion, no seri- 
ous adverse events related to the product was observed. A limit- 
ed number of minor adverse events were recorded. 
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CHARACTERIZATION OF THE CHONDROCYTE-SPECIFIC 
UPSTREAM PROMOTER REGION OF THE HUMAN COL9A1 
GENE 
P. Zhang, S. A. Jimenez, D. C. Stokes 
Division of Rheumatology, Department of Medicine, Jefferson 
Medical School, Thomas Jefferson University, Philadelphia, 
PA 19107, USA 
Aim: The aim of this study was to to characterize the upstream 
chondrocyte-specific (CSU) promoter region of the human 
COL9At gene. 
Methods: Computer analysis of the region from -890 bp to the 
transcriptional start site of the CSU promoter egion predicts at 
least 5 putative SOX/Sry binding sites. Electromobility shift 
assays with oligonucleotide probes encompassing the putative 
SOX/Sry binding sites were performed with bovine fetal chondro- 
cyte (BFC), human chondrosarcoma (HTB), rat chondrosarcoma 
(RCS) and NIH 3T3 nuclear extracts. Co-transfection analyses 
with full-length and deleted COL9A1 CSU-promoter/reporter 
constructs and a SOX9 expression plasmid were performed in 
HTB and RCS cells. 
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Results: Electromobility shift assays with oligonucleotide probes 
encompassing the putative SOX/Sry binding sites revealed spe- 
cific DNA-protein complexes with BFC, HTB and RCS nuclear 
extracts but not with NIH 3T3 nuclear extracts. The DNA-pretein 
complexes that formed with the BFC nuclear extract and the 
COL9AI CSU-promoter probes could be abrogated with an 84 bp 
probe containing the SOX9, SOX6 and L-SOX5 binding sites from 
the human COL2A1 enhancer in competition experiments. Co- 
transfection analyses showed that a COL9AI CSU- 
promoter/reporter construct containing the 5 putative SOX/Sry 
binding sites was activated 20-25 fold in HTB cells by a SOX9 
expression plasmid. A lower level (2-3 fold) of activation was seen 
in RCS cells by cotransfection presumably due to the presence of 
endogenous SOX9. In transient ransfection analyses, deletion of 
the most upstream putative SOX/Sry binding site resulted in a 
negligible decrease in activity whereas deletion of the region con- 
taining the proximal 4 of 5 putative SOX/Sry binding sites result- 
ed in a drastic (85%) decrease in activity in RCS cells. Both dele- 
tion constructs were activated by co-transfection with a SOX9 
expression plasmid in HTB cells. 
Conclusions: These results indicate that SOX9 is a potent acti- 
vator of the COL9A1 CSU-promoter egion and that the organi- 
zation of the CSUpromoter region is similar to that of the 
COL11A2 gene promoter. 
PA34 
LPS STIMULATION UPREGULATES MATRIX METALLOPRO- 
TEINASE-1, -3, p AND -13, CYCLOOXGENASE -2 AND 
AGGRECANASE-1 GENE EXPRESSION 
IN CULTURED BOVINE CHONDROCY'FES 
Xia-di Zhou, Loran Killar, Pin Lu 
Department of Immunology, Inflammation and Pulmonary Drug 
Discovery, BristoI-Myer Squibb Pharmaceutical Research 
Institute, Princeton, NJ, USA 
Objective: To understand the role of chondrocytes in cartilage 
homeostasis, we investigated gene expression levels of matrix r 
metalloproteinases (MMPs), cyctoocygenase (COX), aggrecanas- 
es, and iNOS in cultured bovine chondrocytes timulated with 
LPS. We also evaluated the efficacy of anti-inflammatory agents 
mesotrexate and dexamethasone on the above gene's upregula- 
tion. 
Method: Chondrocytes were isolated from calf cartilage through 
serial enzymatic digestion. Cultured bovine chondrocytes were 
stimulated with LPS w/o the treatment of either mesotrexate or 
dexamethasone. Chondrocytes were then lysed for RNA purifica- 
tion at different ime points. The target gene message was detect- 
ed through real-time PCR with specific primers. The data are pre- 
sented as fold increases over unstimulated cells. All data pre- 
sented here were representative of three independent studies. 
Results: LPS induced MMP-13, -3, -1, COX-2, aggrecanase-1 
and 2 gene expression upregulation in chondrocytes in a dose 
dependent manner but reached plateau at 1 p.g/rnl level. Among 
genes investigated, MMP-13 was most responsive to LPS and 
showed around 1000-800 fold elevation, MMP-3 and COX-2 
genes were around 100 fold increases, while MMP-1 showed only 
around 10-20 fold upregulation. Kinetic study showed that LPS- 
induced response peaked at 24 hours and diminished by 72 
hours, except aggarecanase-2 mRNA peaked at 72hours. mRNA 
levels of proteoglycan, type 11 collagen, iNOS were unchanged. 
Addition of dexamethasone strongly inhibited LPS-induced 
MMP-13, -3, and -I as well as COX-2 gene upregulation. 
Mesotrexate treatment partially inhibited LPS-induced MMP-13, - 
3, and-i gene expression but exacerbated aggracanase-1 expres- 
sion. Moreover, it did not affect elevated COX-2 gene expression. 
Conclusions: LPS stimulation was able to induce significant 
MMPs, cox-2 and aggarecanases gene upregulation in cultured 
bovine chondrocytes. Dexamethasone suppressed all target 
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gene elevation while mesotrexate was less effective. The assay 
has the potential application for screening compounds targeted 
in MMPs and COX-2 in RA or OA. 
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THE EFFECTS OF LOW INTENSITY ULTRASOUND ON 
CHONDROCYTE PROLIFERATION IN VITRO 
Z Zh_..~!, JW Huckle 2 , RGS Spencer 1 
Tl~lational Institutes of Health, National Institute on Aging, 
Baltimore, USA 
2Smith and Nephew Group Research Center, York, UK 
Aim: The clinical success of ultrasound in accelerating fracture 
healing (Sonic Accelerated Fracture Healing System, Smith and 
Nephew), and experimental results demonstrating attenuation or 
reversal of cartilage damage in animal models, highlight the 
importance of characterizing the influence of ultrasound on 
chondrocytes. 
Methods: Chondrocytes isolated from the distal sternum of 16- 
day old chick embryos were cultured in alginate beads or 0.4 % 
agarose. After an initial culture period of 24 hours, chondrocytes 
were exposed to ultrasound for 20 minutes only, using a pulsed 
ultrasound device producing an intensity of 30 mW/cm 2 at 1.5 
MHz. In Group A, the ultrasound transducer was applied directly 
through parafilm to fluid-filled culture dishes. In Group B, tissue 
absorption was mimicked by placing an attenuating el block 
between the transducer and the culture dishes. The delivered 
energy was accordingly reduced to 5 mW/cm 2. In Group C, the 
control group, ultrasound was not applied. Samples of beads or 
agarose were analyzed at days 1, 3, 5 and 7 after application of 
ultrasound. Chondrocytes were dissociated from the gels and 
lysed, after which proliferation was assessed by quantification of 
fluorescent labeled DNA. 
Results: In Group A, ultrasound did not increase chondrocyte 
proliferation. In Group B, exposed to the lower dose of ultra- 
sound, proliferation was increased by 15% over control (p 
<0.001) in alginate culture, and by 20% (p<0.01) in agarose cul- 
ture, after 3 days. 
Conclusion: It has been well-established that the chondrocyte 
phenotype is much better maintained in 3-dimensional than in 2-
dimensional culture systems. To our knowledge, this is the first 
study of the application of ultrasound to chondrocytes in three- 
dimensional culture. The potential for ultrasound to increase 
chondrocyte proliferation as demonstrated in this in vitro model 
clearly adds to the understanding of the mechanism by which 
ultrasound can be of benefit in the treatment of bone and joint 
diseases. 
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THYROID HORMONE INCREASES TRANSGLUTAMINASE 
ACTIVITY IN ARTICULAR CHONDROCY'rES 
A__KK Rosenthal, CM Gohr, DR Heinkel 
Medical College of Wisconsin and Milwaukee VAMC, 
Milwaukee, W/, USA 
Aim: The aim of this study is to determine whether thyroid hor- 
mones increase transglutaminase activity in articular chondro- 
cytes. Calcium pyrophosphate dihydrate (CPPD) crystal deposi- 
tion disease is characterized by the formation of CPPD crystals in 
the periceUular matrix of aging articular chondrocytes. Some fea- 
tures of chondrocytes from patients with CPPD disease resemble 
those of the hypertrophic hondrocytes responsible for normal 
mineral formation in growth plate cartilage. We previously 
showed that hyroid hormone, which induces the hypertrophic 
phenotype in growth plate chondrocytes, also stimulates 
processes linked to CPPD crystal formation in adult articular 
chondrocytes. We recently postulated that the protein cross-link- 
ing enzymes transglutaminases (TGases) contribute to CPPD 
crystal formation in aging cartilage, likely through altering the 
pericellular matrix milieu to promote liberalization. Thus, elevated 
levels of TGase may be an additional component of the "CPPD 
phenotype". 
Method: We incubated adult porcine articular chondrocytes in 
primary high-density monolayer cultures with or without thyrox- 
ine. TGase activity was measured with a standard radiometric 
assay in various cell compartments and extracellular matrix. 
Results: Thyroxine (3"4) increased TGase activity at 4 and 24 
hours in concentrations of 200-750 nM T4. At 4 hours, TGase 
activity was 0.42 + 0.01 U/mg protein in control cultures and 
0.15± 0.09 U/rag protein in cultures incubated with 250 nM T4. At 
24 hours, TGase activity was 0.25 + 0.01 U/mg protein in control 
cultures, and 0.44 + 0.01 U/mg protein incubated with 250 nM T4. 
The addition of 100 mM cycloheximide with T4 did not affect 
TGase activity compared with thyroxine alone at 24 hours, but 
100raM actinomycin decreased TGase to 1/3 of values obtained 
with T4 alone. TGase activity in the matrix fraction increased from 
0.18 ± 0.01 U/mg protein in control cultures to 0.34±0.16 U/mg 
protein with 250 nM 14. TGase activity in membrane fractions 
increased from 0.11+ 0.03 U/mg protein in control cultures to 
0.14 ± 0.06 U/mg protein in cultures exposed to 250 nM T4. No 
changes in cytosolic TGase activity were noted with T4. 
Conclusion: T4 increases chondrocyte TGase activity, most 
notably in matrix, where it may contribute to CPPD mineral for- 
mation. Taken together with previous work, these data support 
the hypothesis that elevated TGase activity is part of the CPPD 
phenotype in aging articular chondrocytes. 
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HOMEOSTASIS OF THE EXTRACELLULAR MATRIX 
BY HUMAN CHONDROCYTES OBTAINED FROM NORMAL 
CARTILAGE 
Wang J., Veys EM., Verbruaaen G. 
Department of Rheumato/ogy, Ghent University Hospital, Ghent 
University, Belgium 
Objective: Synthesis and accumulation of the ECM is regulated 
by locally produced growth factors such as IGF and TGF-~. 
Turnover and degradation of the matrix is dependent on the 
responsiveness of the chondrocyte to catabolic cytokines of 
which IL-lc~ and ~ are the main agonists. The role of auto- and 
paracrine anabolic (IGF-I/IGF-Rel) and of catabolic (IL-Ic~ and 
~/IL-1-Rel pathways in the homeostasis of the extracellular 
matrix (ECM) of articular cartilage was the subject of study. 
Methods: Phenotypically stable human articular cartilage cells 
were obtained from normal cartilage and maintained in culture in 
aigmate beads over 1 week to reach equilibrium in accumulated 
compounds in the cell-associated matrix (CAM). The levels of 
CAM aggrecan, type II collagen and fibronectin, of intracellular 
IGF-I, IL-Ic~ and B and of their respective plasma membrane- 
bound receptors: IGF-Rel, IL-1-Rel and the decoy receptor IL-1- 
Rel were then assayed using flow cytometry. This experimental 
set-up enabled the relation between the auto/paracrine pathways 
and the homeostasis of ECM molecules in the CAM to be inves- 
tigated. The Na-citrate solubilization of the alginate gel has been 
shown not to influence the detection of matrix molecules around 
the cell and epitopes on the membrane. 
Results: Correlation between the IGF-Rel expression on the cell 
membrane and IGF-1 levels inside the cells and the accumulation 
of CAM molecules were obvious. We report a correlation between 
the IGF-1/IGF-Rel pathway and the decoy receptor IL-1-Rel. In 
addition, both these signaling systems that contribute to the 
accumulation of ECM macromolecules were significantly corre- 
lated with the levels of aggrecan, type II collagen and fibronectin 
